James Madison University

JMU Scholarly Commons
Physician Assistant Capstones

The Graduate School

Fall 12-14-2018

Long term outcomes of on-pump CABG versus off-pump CABG
Christopher Fetrow
James Madison University

Jessalyn Dickerson
James Madison University

Follow this and additional works at: https://commons.lib.jmu.edu/pacapstones
Part of the Surgical Procedures, Operative Commons

Recommended Citation
Fetrow CM. Dickerson JD. Long Term Outcomes of On-Pump CABG versus Off-Pump CABG. JMU
Scholarly Commons Physician Assistant Capstones. https://commons.lib.jmu.edu/pacapstones/32/.
Published December 12, 2018.

This Presentation is brought to you for free and open access by the The Graduate School at JMU Scholarly
Commons. It has been accepted for inclusion in Physician Assistant Capstones by an authorized administrator of
JMU Scholarly Commons. For more information, please contact dc_admin@jmu.edu.

Long Term Outcomes of On-Pump CABG versus
Off-Pump CABG
Christopher Fetrow and Jessalyn Dickerson
James Madison University
November 28, 2017

Abstract
Objective: Assess the long-term outcomes including mortality, revascularization and myocardial
infarction events to determine whether off-pump CABG is more effective for patients compared to onpump CABG procedures.
Methods: Studies were found using PubMed with the search term, “on and off pump CABG” which
yielded 1736 studies. After assessing for records within 5 years the search was narrowed to 370 articles
and then down to 353 because some articles were not available in full-text. Our search was then divided
into first looking at randomized control trials and meta-analysis availability from the 353 articles
meeting our criteria. After narrowing our search for only randomized control trials, we were left with 47
articles. We lastly went back to the 353 articles and narrowed that search to only available metaanalysis which gave us 27 options. The final studies were chosen based on their relation to our clinical
question.
Results: Studies show that there are no significant differences in the number of events sustained (or
occurring) after both the off-pump CABG and on-pump CABG procedures. This was evident by results
that varied between the three studies in which all percentages were close in number of events per
population.
Conclusion: In regard to deciding whether to perform on-pump CABG or off-pump CABG, the physician
and patient need to make a joint decision based on the patient’s comorbidities and the physician’s
experience as a surgeon. There is not conclusive evidence that one approach is more effective than the
other.

Introduction
Atherosclerotic plaque buildup in coronary arteries leads to approximately 400,000 patients
across the United States undergoing an invasive procedure called a coronary artery bypass graft (CABG)
each year.1 CABGs remain the most common cardiac surgery in the United States and the standard of
care for patients that suffer from left main coronary artery or 3-vessel coronary artery disease.2
However, there are two approaches to performing the surgery, one which includes a cardiopulmonary
bypass pump and the other procedure which is performed off the cardiopulmonary bypass pump.
Regardless of the approach, the goal of the surgery is to bypass a blockage in a coronary vessel by using
other vessels that have been harvested from another location within the body including internal
mammary arteries, radial arteries and saphenous veins. The procedure is effective in its five-year
outcomes, however it is unclear whether the benefits of off-pump coronary artery bypass graft are more
effective than on-pump artery bypass graft. Among patients that meet criteria for a coronary artery
bypass procedure, does the on-pump CABG procedure as compared to performing the CABG off-pump
improve outcomes (mortality, revascularization, and myocardial infarction)?
On-Pump Procedure
On-pump coronary artery bypass is the more historical of the two procedures. However, it
involves a lot of personnel and machinery to perform it correctly and efficiently. Included in the team
needed to complete the surgery is a cardiothoracic surgeon, cardiothoracic physician assistant,
anesthesiologist, perfusion technologist and the OR nurses. There are two components of
cardiopulmonary bypass which consist of the pump and the oxygenator. In the on-pump procedure,

patients are anesthetized using a neuromuscular blockage agent, anesthetic agent and heparin (IV dosed
with 300-400 mg/kg of heparin) prior to performing a sternotomy in order to expose the
epicardium/myocardium.3 Next, the surgeon implants the cardiopulmonary bypass tubes into the right
atrium with the distal cannula in the inferior vena cava. The aorta is then cannulated distal to the aortic
clamp, with a goal of bypassing the heart and lungs once the heart is stopped for the procedure.4 During
this time, the patient’s heart is put into a mild hypothermic state at approximately 34C to prevent brain
and vital organ tissue injury.5
At this point the heart is subsequently stopped using a potassium solution in addition to the
hypothermia and the pump starts to pull the deoxygenated blood from the right atrium and takes it to
the oxygenator. Inevitably, during oxygenation, oxygen bubbles are introduced to the blood which are
filtered out prior to leaving the oxygenator. Lastly, the pump pushes the oxygenated blood from the
oxygenator to the aorta in order to perfuse the body.3 Upon completing the procedure, the
temperature of the patient must be returned to 37C at a rate of ≤0.5C/min which could take 60-90
minutes.6
Once the bypass is set up, the CABG procedure is initiated by first harvesting the vessels needed
to bypass the blockage(s). These vessels include the internal mammary artery, saphenous vein and radial
artery depending on how many coronary vessels need to be bypassed. The arteries and/or veins are first
sewed to a slit made in the aorta which will be the primary source of blood to that part of the heart.
Lastly, the opposite end of the harvested vessel will be attached to a slit made in the blocked coronary
vessel distal to the blockage, thus making a patent bypass. Prior to closing the patient, the surgeon will
ensure patency and blood flow to the myocardium through the new vessels. The heart is capable of
starting on its own; however, defibrillators are occasionally used along with temporary pacemakers.7
Off-Pump Procedure
Many of the preparatory steps of the off-pump coronary artery bypass procedure are similar to
the on-pump however, the repair of blockages of the coronary artery or arteries is completed while the
heart continues to beat. This procedure is also referred to as OPCABG (Off Pump Coronary Artery Bypass
Graft)and is different than the traditional on-pump surgery that requires the usage of a heart and lung
bypass machine. Special devices are utilized to stabilize and partially immobilize the specific tissues of
the heart that the surgeon is repairing.8
Not all candidates that need a CABG are eligible for the off-pump procedure. Individuals who are
at high risk are believed to benefit more from an off-pump CABG instead of an on-pump. These
individuals include people with advanced atherosclerosis of the aorta, kidney problems and chronic lung
disease.9 Other candidates who might be considered for an OPCAB include patients that are over the
age of 60 with multiple diseased vessels, history of stroke, poor heart function or are
immunosuppressed. Individuals who would not be considered for this procedure include patients that
have enlarged hearts, valvular disease or blockages into the myocardium.10
As with any surgical procedure,there are potential risks and specific complications associated
with the off-pump CABG that include but aren’t limited to heart attack, stroke, bleeding, deep wound
infection, arrhythmias or irregular heartbeats along with potential nerve damage. The OPCABG is
thought to have a slightly lower risk of complications unless there are other risk factors such as diabetes,

obesity, smoking or alcoholism.10 The procedure is believed to provide benefits such as a lower stroke
risk, neurocognitive dysfunction, organ dysfunction and atrial fibrillation.8

Clinical Question
Prior to starting the investigation for studies to examine, a PICO, a framework used to develop a
clinical question to use in search engines when investigating a topic, was created and is found in table 1.
We were able to interview local health professionals in cardiothoracic surgery and found that coronary
artery bypass surgeries are the most common surgeries performed. The population was defined as being
any patient that meets the criteria of the American College of Cardiology Foundation and American
Heart Association guidelines for CABG which was developed in collaboration with American Association
for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society for Thoracic Surgeons. Our
goal was to compare the outcomes of off-pump CABG to the on-pump CABG by using selected outcomes
which were based off the most reliable and recent studies found and their measured outcome
congruency which were mortality, revascularization and myocardial infarction.
Table 1. PICO Framework Table
P
Population
Patients that meet criteria for a coronary artery bypass procedure
I
Intervention
On-Pump CABG
C
Comparison
Off-Pump CABG
O
Outcome
Revascularization, Mortality and Myocardial Infarction

Clinical Question:
Among patients that meet criteria for a coronary artery bypass procedure, does the on-pump CABG
procedure as compared to performing the CABG off-pump improve outcomes (mortality,
revascularization and myocardial infarction?

Methods
Our search started with Google Scholar and Pubmed by searching “on and off pump CABG”.
Google scholar led us to all articles presented by Pubmed which had a total result of 1736 studies. There
were no duplicates to remove. After assessing for records within 5 years, the search was narrowed to
370 articles and then down to 353 because of some articles not being available in full-text. Our search
was then divided by first looking into randomized control trials and meta-analysis availability from the
353 articles meeting our criteria. After narrowing our search for only randomized control trials, we were
left with 47 articles. We chose “Five-year outcomes after on-pump and off-pump coronary artery
bypass” and “Five-Year Outcomes after Off-Pump or On-Pump Coronary-Artery Bypass Grafting”
because they allowed us to assess outcomes for 30 days up to 5 years which was hypothesized to be
helpful in determining long term outcomes of both procedures. We lastly went back to the 353 articles
and narrowed that search to only available meta-analysis which gave us 27 options. We chose “Current
evidence of coronary artery bypass grafting off-pump versus on-pump: a systematic review with metaanalysis of over 16,900 patients investigated in randomized controlled trials” because it had the most
total patients and lined up with parameters found in the two randomized control trials we chose that

included mortality, revascularization rates, and incidence of subsequent myocardial infarctions. A PRIMA
flow diagram of our systematic review is depicted in figure 1.

Examined Studies

Figure 1. Prisma Flow Diagram 11

Study #1
Five-Year Outcomes after Off-Pump or On-Pump Coronary-Artery Bypass Grafting12
Objective: Evaluate the outcome of death, stroke, myocardial infarction, or renal failure between
patients who underwent coronary-artery bypass grafting (CABG) performed with a beating heart
technique (off-pump) and those who underwent CABG performed with cardiopulmonary bypass (onpump) at 5 years.
Study design
This was a randomized controlled trial with blinded adjudication of outcomes where off-pump
CABG and on-pump CABG were compared. Patients required an isolated CABG with median sternotomy
along with one or more of the risk factors as seen in Table 2. A total of 4752 patients, from 79 various
hospitals in 19 countries on four continents were randomly assigned to undergo a CABG procedure
either on or off-pump. The surgeons have expertise in the specific assigned type of surgery to be
performed with more than 2 years of experience after residency training and completion of more than

100 cases. If expertise in both techniques are met by a specific surgeon, they would be able to perform
both type of procedures.
Follow-up with the patients was conducted in-person and on the telephone either with the
patient or with their next of kin at 30 days and at 1 year after the procedure on a yearly basis until the
end of the trial. If an outcome event is indicated the patient’s physician was contacted to obtain source
documentation concerning that specific event. The outcomes measured include death, nonfatal stroke,
nonfatal myocardial infarction, nonfatal new renal failure requiring dialysis, and repeat coronary
revascularization. These outcomes are divided into first coprimary which are being assessed at 30 days
and 1 year and the secondary coprimary that are all identical to the first with the exception of the
repeat coronary revascularization noted with an asterixis in Table 3.All deaths within the first 30 days
were accounted for as cardiovascular deaths. Quality of life assessments were also evaluated with selfrated health scoring between 0 to 100%, with the higher score being a healthier status. Neurocognitive
tests were also performed before the CABG, at discharge, 30 days, and at 1 year but not at the 5-year
follow-up. Because no assessment was performed at 5 years this assessment was not included in this
report.
The conduction of all analyses was completed according to the intention-to-treat principle,
along with a time-to-event analysis with regression to report the long-term outcomes, after testing the
assumption of proportional hazards. The first occurrence of the primary outcome is depicted with the
Kaplan-Meier survival curves, and then the comparison between the two different treatment groups
was compared with a log-rank test. The hazard ratio with 95% confidence intervals is used to
demonstrate treatment effect derived from the Cox proportional-hazards model for the second
coprimary outcome at 5 years. The two operative techniques are assessed within prespecified
subgroups as seen in Table 3. If the patient had outcomes evaluated at 1 year without follow-up data,
the info was excluded.
Table 2. Risk Factors determined by age
Age 70 years or more with 1 or more of the
following risk factors:
Peripheral arterial disease, cerebrovascular disease
or carotid stenosis or 70% or more of the luminal
diameter, or renal insufficiency.

Age 60-69 years of age with at least 1 of the following
risk factors or age 50-59 years with at least 2 risk
factors:
Diabetes requiring treatment with an oral
hypoglycemic agent or insulin, the need for urgent
revascularization after an acute coronary syndrome, a
left ventricular ejection fraction of less than 35%, or a
history of smoking within 1 year before
randomization.

Table 3. Coprimary outcomes
Outcome Events
Death
Nonfatal stroke
Nonfatal myocardial infarction
Nonfatal new renal failure requiring dialysis
Repeat coronary revascularization*
Table 4. Prespecified Subgroups
Subgroups
Diabetes Status
Cerebrovascular disease status
Left ventricular function
Number of disease vessels
Sex
Age
Body-mass index
Region
European System for Cardiac Operative Risk Evaluation (EuroScore)
Study Results
No significant differences were noted between the off-pump and on-pump CABG groups in the
rate of composite outcome (23.1% and 23.6%, hazard ratio with off-pump CABG 0.98, 95% CI 0.87 to
1.10; P=0.72) or in the rates of the components of the outcome, including repeat coronary
revascularization. Repeat revascularization was performed in 2.8% of the patients in the off-pump group
and in 2.3% of the patients in the on-pump group (hazard ratio, 1.21; 95% CI, 0.85 to 1.73; P=0.29). No
significant differences between groups in the quality-of-life measurements or the cost of the procedures
was shown either. Based on this study, both procedures are equally effective and safe. To validate the
consistency and validity of the results the treatment effects within the various subgroups were analyzed.
It was determined that there were no significant interactions in the prespecified groups. The exception
to this was the diabetes status group which showed an increase of secondary outcomes among the
diabetics who underwent the off-pump CABG and a decrease in diabetics who had on-pump CABG. An
apparent differential effect of treatment is therefore found among patients with diabetes.
Study Critique
No specific reasoning for the difference among the diabetes status subgroup was given and
could not be validated with a significant interaction supported by other studies and additional
information. Within the various subgroups the confounding variables were not treated any differently
regardless of the intervention, with the exception being diabetics. There appeared to be an interaction
between CABG type and diabetes status. Due to no significant findings between the treatment groups
statistically or financially, a standard cost-effectiveness analysis was not completed. The specific cost of
the supplies used for the procedures were not provided so a definitive cost analysis was unable to be
completed. The quality-of-life and neurocognitive tests were optional for patients and not completed by
everyone. An assessment at the end of the trial for neurocognitive status was unable to be completed.

There are many variabilities within this study including the variety of risk factors, and the
country or continent which the procedure was completed. These individuals were randomly selected for
each procedure, but some risk factors might have been more compatible with one procedure over the
other resulting in different outcomes. The patients were randomized with blinded adjudication of
outcomes. Other than the interventions the patients were all treated the same with follow-up and prior
to interventions. The patients were aware of the intervention that would be occurring but were
unaware as to why there were selected for that specific intervention. Follow-up data was provided for
98.8% of the patients and missing patients aren’t addressed within the study.
Other things to be considered is that the quality-of-life measurement is subjective and may not
accurately depict the improvement or decline in the quality-of-life for each patient. If no follow-up data
was provided after outcomes evaluated at one year then this information would have been excluded
from the study, potentially skewing the data from accurate evaluation and numbers with no follow-up
data provided. Although these individuals don’t want to be falsely accounted for either, if they had
outcomes but no follow-up then the information is misleading.
The founding of this specific study was supported by the Canadian Institutes of Health Research.
There was also grant support from Abbott Diagnostics, Boehringer Ingelheim, Covidien, Octapharma,
Roche Diagnostics, and Stryker. Based on these grants there was likely a conflict of interest for the
products and interventions. There were no other potential conflict of interests that were relevant or
reported within the article.
Study #2
Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass13
Objective: To determine the 5-year clinical outcomes of patients included in the Veterans Affairs trial of
on-pump versus off-pump CABG.
Study design
The original trial was a randomized, controlled, single-blinded trial that looked at the 1-year
assessment of outcomes in CABG procedures. These same participants were used under the same trial
methods to look then at the 5-year clinical outcomes. The mortalities that occurred within the last 5
years was assessed by using the data in the VA (Veteran Affairs) Vital Status Files along with the National
Death Index to determine the cause of death. Chart reviews and databases like the VA National Patient
Care Database, VA Patient Treatment File, VA-purchases care files, and Medicare Part A and B records
were used to identify the nonfatal myocardial infarctions and repeat revascularization procedures.
Death from any cause, and MACE or major adverse cardiovascular events (a composite outcome
of death from any cause, repeat revascularization [CABG or PCI], or nonfatal myocardial infarction) were
the two primary outcomes monitored from the date of surgery to 5 years following the CABG.
Comparisons between these two outcomes was then made between off-pump and on-pump
treatments. Secondary outcomes included in the 5-year rates of death from cardiac causes, nonfatal
myocardial infarction and repeat revascularization. Death from cardiac causes (rather than death from
any cause), repeat revascularization or myocardial infarction was also assessed as additional secondary
5-year composite outcomes.
A committee consisting of cardiologists, cardiac surgeons, and the national nurse coordinator all
were blinded to the treatment assignments of the patients and reviewed the trial outcomes. Initially
assigned end-point categories made by the committee to medical charts included cause of death due to
cardiac, non-cardiac or unknown etiologies. After these initial classifications were assigned, the

committee compared these causes of death to the cause-of-death coding in the National Death Index
and a final classification was then determined. If the committee didn’t have sufficient data to determine
a cause of death the National Death Index Coding cause of death was used.

Study Results
The patients used in the 5-year-follow-up study were monitored after randomization. At
baseline the demographic characteristics and the risk characteristics did not significantly differ between
the on-pump and off-pump treatment groups because the characteristics of patients at baseline were
equal between the treatment types. The follow-up study used bivariate statistical comparisons for the
hypotheses. This study was 99.4% men and the mean age was 62.7 years. Either two-vessel or threevessel disease, hypertension, and normal or mildly depressed ejection fraction was present in most of
the patients. This study represented the male veteran population who underwent CABG with coronary
disease of mild-to-moderate severity and multiple coexisting conditions.
Table 5 shows the study outcome results within the 5 years following a CABG procedure. These
outcomes were then evaluated in both primary and secondary outcomes. The primary outcome showed
a significantly higher rate of 15.2% in the off-pump group compared to 11.9% in the on-pump group for
the rate of death. The primary outcome MACE at 5 years also showed a significant difference between
the off-pump group and the on-pump group at 31.0% and 27.1%, respectively (P=0.046). These numbers
are reflected in Table 6. No statistical significance was found among any of the secondary outcomes
between the on-pump and off-pump groups. Table 7 shows the difference between the treatment
groups for secondary outcomes.
Table 5. Study Outcomes
Outcome
Number of patients
Deaths
299 deaths (13.6%)
128 cardiac-related death* (5.8%)
Nonfatal myocardial
239 patients (10.8%)
infarction
Repeat
279 patients (12.6%)
revascularization
Table 6. Primary Outcomes
Outcomes
Off-pump
Death
15.2%
Primary MACE
31.0%
outcome
Table 7. Secondary Outcomes
Outcomes
Off- pump
Death from
6.3%
cardiac causes
Nonfatal
12.1%
myocardial
infarction
Repeat
13.1%
revascularization

On-pump
11.9%
27.1%

On-pump
5.3%
9.6%

11.9%

Study Critique
This study included patients within the Veterans Affairs trail which isolates a very select group of
individuals. This group of patients had increased rates of hypertension, peripheral vascular disease and
atrial fibrillation. The urgent status of these patients was also lower, along with lower rates of diabetes
and female sex. Most of the participants in this study were men and don’t accurately account for a
significant number of females as a comparison. This study doesn’t account for major cardiovascular
events such as stroke rates post procedure.
Unfortunately, the care for veterans prior to, during and after service is not always the best
which could lead to the higher rates of other comorbidities. Accounting for the overall health of these
individuals although both group’s risk characteristics were equal, they might have been poor prior to the
procedure. With only looking at veteran individuals it’s hard to make the same comparisons to nonveteran groups of individuals.
Study #3
Current Evidence of Coronary Artery Bypass Grafting Off-Pump Versus On-Pump: A systematic review
with meta-analysis of over 16,900 patients investigated in randomized controlled trials14
Objective: To determine the current strength of evidence for or against off-pump and on-pump coronary
artery bypass grafting (CABG) with regard to hard clinical end-points, graft patency and costeffectiveness.
Study Design
This study was a meta-analysis that totaled 16,904 patients in a sum of 51 studies using the
guidelines for Quality of Reporting of Meta-analysis. The electronic literature search was performed on
March 5th, 2014 using Pubmed, EMBASE, and The Cochrane library. All 51 studies were published
between February 1999 and March 2013. The 51 studies were chosen based off an extensive list of
inclusion and exclusion criteria seen in table 8.
Among the 16,904 patients in this meta-analysis, 8,453 received an off-pump CABG through a
median sternotomy. The age range of the patients in this study varied from 54.0-76.1 years of age. On
average the patients receiving an off-pump CABG had ejection fractions that were 1.8% higher than the
on-pump population. Our main focus for this review was to evaluate the clinical outcomes which were
measured as mortality, repeat revascularization, myocardial infarction, cerebrovascular accidents, low
cardiac output, renal dysfunction, length of hospital stay (cost) and “other clinical outcomes” such as
transfusion and infection.
All the data including authorship, year of publication, type of publication, study design, length of
follow-up, patient population, number of performed distal anastomosis, length of ventilation, ICU
(Intensive Care Unit) and hospital stay, and desired clinical endpoints were extracted. Research quality
assessment was performed by the investigators using the Jadad score and Down and Black checklist
(measures methodological quality; High if score > 21) with disputes being resolved by consensus.
Statistical analysis was performed using the Review Manager Software and StatsDirect. The
authors used I2-statistics for heterogeneity between the studies that were included in the meta-analysis.
The Mantel-Haenszel method was used between studies without heterogeneity and the DerSimonian
and Laird random effects model was used when heterogeneity was present. The effect estimates of

categorial data were calculated as weighted averages in the form of odds ratio and its 95% confidence
interval. For continuous variables, the weighted mean differences (WMD) below 0 showed favoritism
towards off-pump over on-pump CABG. Publication bias was also measured using the Egger’s weighted
regression statistic which was applied with a P-value <0.05. The subsequent studies showing significant
publication bias were investigated by the authors by analyzing subgroups of the study to ensure high
quality.

Table 8. Inclusion and Exclusion criteria for research studies included in the meta-analysis
Inclusion
Exclusion
All studies published in full-text or abstract form
Animal studies
were eligible for inclusion
In vitro studies
All randomized control trials comparing on-pump
and off-pump CABG and reporting at least one
Prevention trials
event in one of the predefined clinical outcome
parameters:
Editorials
- Surgical myocardial revascularization
through a median sternotomy
Letters
-

Comparing off-pump CABG myocardial
revascularization to on-pump CABG

Review articles or trials that reported other
clinical outcomes

-

At least one reported event on the
incidence of desired postoperative
clinical end-points
a) Mortality
b) Myocardial infarction/damage
c) Cerebrovascular accident
d) Repeat revascularization

Studies not including a proper control group
Studies that did not report an event or a desired
end-point
Those that included the same patient population
in more than one publication
Those that only reported the protocol of an
included trial

Study Results
Results can be found in table 9 which shows the parameters in which all of the studies
investigated following on-pump versus off-pump CABGs. Each parameter varied in sample size because
all of the 51 studies that were looked at did not measure all of the same parameters. The study found
that mortality rates short-term (30 days) or long-term (1-7 years), myocardial infarctions and
cerebrovascular accidents were no different between the two surgical approaches. However, off-pump
CABG showed a 1.9-fold increase in risk of requiring a repeat revascularization with the first 30 days
post-surgery. Additionally, cardiopulmonary bypass caused a 2-fold increase in low cardiac output, but
when off-pump was performed, they saw a 45% risk reduction. Lastly, renal dysfunction risk was
reduced by 2.1% with off-pump CABG. Length of stay in the ICU was changed with off-pump CABGs,
showing a WMD -.36 days with a total hospital stay decrease shown by a WMD of -1.04 days. Off-pump
CABG also showed a reduction of as a result of shorter duration of hospital stays, total costs were
diminished by a WMD of -2,369 dollars. This could all be due to the reduction of the length of ventilation
following off-pump CABG supported by a WMD of -3.50 hours.

Table 9. Analyzed clinical outcomes comparing on-pump versus off-pump CABG.
Dichotomous

Sample
size (n)

Prevalence %
(n)

OPCAB %
(n)

CABG %
(n)

OR (95% CI)

χ²-test
(P-value)

Death

16,718

2.0% (328)

1.8% (151)

2.1% (177)

0.86 (0.69–1.06)*

0.1606

Cardiac death

6,506

2.0% (130)

1.9% (63)

2.1% (67)

0.94 (0.66–1.32)**

0.7795

Myocardial

12,496

4.7% (589)

4.6% (285)

4.9% (304)

0.93 (0.79–1.10)†

0.4450

10,840

0.59% (64)

0.8% (42)

0.4% (22)

1.87 (1.13–3.11)††

0.0176

15,562

1.5% (237)

1.3% (100)

1.8% (137)

0.74 (0.58–0.95)‡

0.0186

2,245

6.8% (153)

4.9% (56)

8.8% (97)

0.52 (0.37–0.73)‡‡

0.0003

13,052

12.0% (1571)

11.0% (718)

13.1%

0.79 (0.71–0.89)§

0.0003

infarction
Repeat
revascularization
Cerebrovascular
accident
Low cardiac
output
Renal
dysfunction
Renal

(853)
12,212

1.5% (179)

1.3% (78)

1.7% (101)

0.78 (0.58–1.04)§§

0.0945

10,709

21.8% (2339)

21.2% (1139)

22.5%

0.77 (0.59–1.01)•

0.1160

replacement
Atrial
fibrillation

(4232)

Infection

10,801

5.6% (600)

4.7% (255)

6.4% (345)

0.72 (0.60–0.85)••

<0.0001

Rethoracotomye

11,710

2.3% (268)

2.1% (121)

2.5% (147)

0.82 (0.64–1.04)◊

0.1099

Transfusiona

11,595

45.6% (5286)

40.4% (2344)

50.8%

0.60 (0.47–0.75)◊◊

<0.0001

(2942)
Thirty-day follow-up. Summary of pooled effect estimates of all included trials reporting data of clinical outcomes off-pump coronary
bypass (OPCAB) or coronary artery bypass surgery (CABG) with the use of the cardiopulmonary bypass. Effect estimates were
calculated in the presence (I2 > 50%) or absence of heterogeneity among trials by using either the random effects (DerSimonian–Laird)
or fixed effects method (Mantel–Haenszel) as indicated.
CI: confidence interval; n: number of patients; OR: odds ratio with values less than 1 favoring OPCAB.
aIndicating recipients transfusion.
* Heterogeneity: I² = 0%, fixed effects (Mantel–Haenszel): overall effect P = 0. 1687.
** Heterogeneity: I² = 0%, fixed effects (Mantel–Haenszel): overall effect P = 0. 7825.
† Heterogeneity: I² = 0%, fixed effects (Mantel–Haenszel): overall effect P = 0. 4311.
†† Heterogeneity: I² = 46%, fixed effects (Mantel–Haenszel): overall effect P = 0. 0191.
‡ Heterogeneity: I² = 0%, fixed effects (Mantel–Haenszel): overall effect P = 0.0229.
‡‡ Heterogeneity: I² = 8%, fixed effects (Mantel–Haenszel): overall effect P = 0.0002.
§ Heterogeneity: I² = 0%, fixed effects (Mantel–Haenszel): overall effect P < 0.0001.
§§ Heterogeneity: I² = 0%, fixed effects (Mantel–Haenszel): overall effect P = 0.1024.
• Heterogeneity: I² = 79%, fixed effects (Mantel–Haenszel): overall effect P = 0.0594.
•• Heterogeneity: I² = 0%, fixed effects (Mantel–Haenszel): overall effect P < 0.0001.
◊ Heterogeneity: I² = 15%, fixed effects (Mantel–Haenszel): overall effect P = 0.1082.
◊◊ Heterogeneity: I² = 79%, fixed effects (Mantel–Haenszel): overall effect P < 0.0001.

Study Critique
The main goal of this meta-analysis was to determine the strength of evidence for or against offpump CABG and on-pump CABG. 16,904 patients that were eligible for Coronary Artery Bypass Graft
procedures were assessed through 51 different studies. The outcomes were evaluated using hard
clinical end-points, graft patency, and cost-effectiveness. The investigators searched PubMed, EMBASE
and The Cochrane Library independently using a predefined keywords list. All eligible studies for
inclusion were published in full-text or abstract form. No language restrictions were enforced.
Inclusion and exclusion criteria can be found in Table 8.
All randomized controlled trials comparing Off-Pump CABG and On-Pump CABG and reporting at
least one event in one of the predefined clinical outcome parameters were identified and analyzed using
the following a priori defined inclusion criteria: (i) surgical myocardial revascularization through a
median sternotomy; (ii) studies comparing off-pump myocardial revascularization and on-pump surgery
using CPB with cardioplegic arrest and (iii) at least one reported event on the incidence of desired
postoperative clinical end-points: (a) mortality, (b) myocardial infarction or damage, (c) CVA and (d)
repeat revascularization. The end-point definitions used by the primary authors (i.e. myocardial
infarction) were accepted. The methodological quality of the included studies was assessed by two
independent investigators (Antje-Christin Deppeand Wasim Arbash) using the Jadad Score [total score
from 0 (poor) to 5 (excellent)] for RCT, and the Downs and Black Checklist [total score from 0 (poor) to
29 (excellent)] for both RCT and observational trials. Disagreements regarding the scores were resolved
by consensus.
Regarding our desired parameters of revascularization, mortality and myocardial infarction,
there was mild heterogenicity between studies in revascularization and mortality measurements. While
the effect estimate of in-hospital mortality was associated with a higher grade of heterogeneity (I² =
46%), the follow-up data for repeat revascularization were less heterogeneous (I² = 19%). The
investigators did not deem these numbers as significant heterogeneity, so a fixed-effect model was
applied in the analyses. Data between studies measuring incidents of myocardial infarctions showed no
heterogenicity. Authors did not elicit any conflicts of interest.
The authors concluded that both strategies are suitable for CABG procedures. The choice of
procedure should be individualized for each patient according to associated comorbidities, life
expectancy and the surgeon’s training. The p-values vary depending on the outcome. In regards to our
three main outcomes, the p-values were high for myocardial infarction (p= 0.4311) and mortality
(p=0.1606). As a result, you cannot reject the null hypothesis that there is no difference between onpump and off pump CABG resulting in myocardial infarction and mortality. Lastly, the null hypothesis of
no difference between on vs off-pump CABG resulting in repeat revascularization can be rejected due to
low p-value (p=0.0176).14
The meta-analysis was informational because it has a large number of patients receiving on and
off-pump CABG which were compared. The advantage to pulling 51 studies together was that the
authors could acquire info about many different outcomes to gain evidence as to which procedure is
better. The study did not just limit itself to physical outcomes in determining which approach is most
beneficial to the patient. By including both physical parameters and non-physical parameters, the
authors portrayed they were investigating for the patient and not just for research purposes.
The numbers were portrayed in a chart (table 8) that was easy to read however the numbers
within the description were somewhat cryptic. I would have liked the results section to be more
informational about what numbers were considered significant especially when the number of patients

being examined is so large. The revascularization results showed too much heterogeneity to include in
our final results (I2= 45%). Additionally, it might have been easier to report studies that used the same
outcomes because the number of patients varied depending on outcome used.
A strong limitation to the study was the large number of trials reporting very small sample
groups that included small amounts of events on clinical end-points. It is therefore unknown if the
incidence of clinical end-points were underestimated. This study was also limited by the patient
selection bias of the individual trials by including only healthy patients or excluded patients at risk who
might benefit the most (low left ventricular ejection fraction, peripheral arterial disease, diabetes, renal
dysfunction and senescence). Lastly, the experience of off-pump CABG surgeons was varied between
studies.

Discussion
There is a mixture of conclusions between studies. The first study showed no significant
difference between the on-pump and off-pump treatment groups including the quality of life. The
second study, discovered an increase in the rate of death among the off-pump patients along with an
increase of MACE outcomes including deaths from any cause, repeat revascularization and nonfatal
myocardial infarctions. The secondary outcomes however showed no significant difference. The second
study was composed of male veterans with comorbidities (hypertension, peripheral vascular disease,
and atrial fibrillation) which may have led to increased negative outcomes following CABG. The metaanalysis, evaluating a larger scale of patients and populations within the different treatment groups
showed no significant differences in myocardial infarction or cerebrovascular accidents following a CABG
procedure. Some risk reductions were noted in the off-pump treatment group including a risk reduction
in low cardiac output, renal dysfunction, length of stays in the ICU following intervention and the total
cost.
By putting all of the study’s results to the outcomes together, it was determined that 100 people
would need to be treated with off-pump CABG to see an incidence of mortality as compared to on-pump
CABG. Additionally, it was determined that 100 patients would need to be treated with on-pump CABG
for a need of repeat revascularization as compared to off-pump CABG. It is important to note that the
third study was omitted from this factor because of degree of heterogeneity between studies found in
that outcome among the 51 studies. Lastly, It was determined that 500 patients would need to be
treated with an off-pump CABG to have an occurrence of myocardial infarction as compared to on-pump
CABG.
The second randomized control study had 2,203 patients enrolled that received both on-pump
and off-pump CABGs. Within the primary outcomes this study revealed that 30 people needed to
receive on-pump CABG for one less death to occur, 26 people needed to be treated with an on-pump
CABG for 1 less MACE to occur. Death occurred in 168 patients out of 1,104 receiving the off-pump
CABG (15.2%), while it occurred in 131 patients ouf of 1,099 receiving the on-pump CABG (11.9%). When
subtracting the two, the result is an absolute risk reduction (ARR) of 0.033 (ARR= 0.0152-0.0119= 0.033).
This results in 30 patients that need to be treated (NNT) with an on-pump CABG for one less death to
occur (NNT= 1/0.033). There were 342 patients out of 1,104 that suffered from a major adverse cardiac
event or MACE in the off-pump CABG group (31%) and 298 patients out of 1,099 also suffered a MACE
within the on-pump CABG group (27.1%). When these two groups are subtracted from each other, the

result is the absolute risk reduction (ARR) of 0.039 (ARR= 0.031-0.0271= 0.039). A total of 26 patients
need to be treated (NNT) with an on-pump CABG for 1 less MACE to occur (NNT= 1/0.039).
Also within the second study there were secondary outcomes that showed that 100 people
needed to be treated for 1 less death from cardiac causes, 40 people needed to be treated with an onpump CABG for 1 less non-fatal myocardial infarction to occur and finally that 83 people needed to be
treated with an on-pump CABG for 1 less repeat revascularization to be completed. A death from
cardiac cause occurred within 70 patients out of 1,104 within the off-pump CABG group (6.3%) as well as
58 patients our of 1,099 within the on-pump CABG group (5.3%). When subtracting these two groups
from each other, the result is the absolute risk reduction (ARR) of 0.01 (ARR= 0.063-0.053=0.01). The
result is that 100 people need to be treated (NNT) with an on-pump CABG for 1 less death of cardiac
cause to occur (NNT= 1/0.01=100). A non-myocardial infarction occurred in 134 patients out of 1,104 in
the off-pump CABG group (12.1%) and in 105 patients out of the 1,099 in the on-pump CABG group
(9.6%). When subtracting these two from one another, the result is the absolute risk reduction (ARR) of
0.025 (ARR= 0.0121-0.096=0.025). The result is that 40 people need to be treated (NNT) with an onpump CABG for 1 less non-fatal MI to occur (NNT= 1/0.025=40). A repeat revascularization occurred in
145 patients out of 1,104 within the off-pump CABG (13.1%) and in 131 patients out of 1,099 in the onpump CABG group (11.9%). When subtracting these two from one another, the result is the absolute risk
reduction (ARR) of 0.012 (ARR= 0.0131-0.0119=0.012). The result is that 83 people need to be treated
(NNT) with an on-pump CABG for 1 repeat revascularization to occur (NNT= 1/0.012=83).
In the meta-analysis (study number 3), 333 patients needed to receive off-pump CABG for one
less death and one less myocardial infarction to occur. Myocardial Infarction occurred in 285 out 6,295
patients receiving off-pump CABG (4.5%) and 304 out 6,291 patients receiving on-pump CABG (4.8%).
When subtracting the two, the result is an absolute risk reduction (ARR) of 0.003 (ARR= 0.048-0.045=
0.003). The result was 333 patients that need to be treated (NNT) with off-pump CABG for one less
myocardial infarction to occur (NNT= 1/.003). Similarly, off-pump CABG resulted in 151 patient deaths
out 8,363 patient procedures (1.8%) and 177 patient deaths out of 8,355 on-pump procedures (2.1%)
that yielded an ARR of 0.003. The NNT was also 333 patients that needed to be treated with off-pump
CABG to prevent one death. Repeat revascularization was needed in 42 off-pump patients out of 5,616
(0.7%) compared to 22 on-pump patients out of 5,625 (0.4%). The result was an ARR of 0.003 leading to
333 patients needing to be treated with on-pump CABG for one less repeat revascularization to occur.
Patients that require a coronary artery bypass graft often are experiencing other comorbidities
and risk factors. There are numerous things to consider when attempting to account for the variability
within these results. Comorbidities such as hypertension, renal failure and peripheral vascular disease
are risk factors that may impact a patient’s status as a candidate for each procedure. The severity of the
coronary disease, demographic and risk characteristics were similar among the patients undergoing the
studies. The consensus from these studies reveals no significance between the on-pump and off-pump
CABG long term outcomes.

Conclusion
Coronary artery bypass graft is critical in the management of coronary artery blockages to
sustain life. The decision to perform on-pump versus off-pump CABG depends on the patient and
physician having strong communication about comorbidities, surgeon skillset, and risk analysis. Risks
and benefits of each procedure need to be completely disclosed to the patient based off of the risk
analysis performed by the surgeon. More research needs to be done on the long-term effects based on

patient characteristics prior to surgery as well as cost effectiveness post operatively. Additionally, it is
not possible at this time to determine which approach is more beneficial because not all surgeons are
able to perform the off-pump CABG at the same skill level due to years of experience, mentosr, and
number of opportunities to perform these surgeries. Each study however, has shown that on-pump and
off-pump CABG procedures have their risks and benefits allowing for a current conclusion that one
approach is not inferior to the other.
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